Budget 2018-19

  Experts say more real-world studies are required now Bharat Biotech has updated the efficacy of Covaxin to 65.2% against the  De lta variant  in – Effectiveness Study on Delta Variant – Lancet Infectious Diseases, published on Nov 23 2021. “Bharat Biotech commends the investigators from the All India Institute of Medical Sciences (AIIMS) on the BBV152 study published in Lancet Infectious Diseases. These results provide evidence for effectiveness for Covaxin in real life settings,” Bharat Biotech said. It added that an effectiveness result of 50% achieved during the peak Covid-19 Delta variant wave in India, in a high risk study population of physicians and health care workers, in a hospital environment, and who are challenged repeatedly with high viral loads, provides insights into the efficacy and effectiveness of Covaxin.. “These results compare well with the 65.2% efficacy against the delta variant obtained during the controlled phase III clinical trials of  Cov...

  Doctor says people should remain vigilant, as the infection can “spread to the elderly” and trigger “serious symptoms” v A fresh wave of coronavirus   cases in Delhi   has “mainly affected” the young with most of the patients reporting “relatively milder symptoms”, AIIMS   director Dr Randeep Guleria told  Indian Express .People should remain vigilant, as the infection can “spread to the elderly” and trigger “serious symptoms”. If so happens then the healthcare resources would come under strain yet again, he said.. Guleria told  Indian Express  that having more containment zones within a city would be a better strategy in containing the spread as some states mulled over imposing another lockdow Delhi   has been witnessing over 1,500 daily cases over the past five days, with 995 cases reported on Wednesday. This has resulted in Delhi   getting back in the top 10 of most cases. “As of now, most of the patients who are comi...